GSK/THRX—Relvar Ellipta approved for asthma in Japan: http://finance.yahoo.com/news/relvar-tm-ellipta-tm-gains-070000827.html See #msg-92194902 for background. I don’t know why application wasn’t reviewed for COPD in Japan.